Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA8083 VoclosporinSummary: A calcineurin phosphatase inhibitor. -
BA8103 HKB99Summary: HKB99 is a variant inhibitor of phosphoglycerate mutase 1. -
BA8137 SHP389Summary: SHP389 is a metastable inhibitor. -
BA8161 TMX-4100Summary: TMX-4100 is a selective phosphodiesterase 6D degrader. -
BA8210 TanimilastSummary: Tanimilast (CHF-6001) is a novel potent and selective inhibitor (=0.026±0.006nM) with potent anti-inflammatory activity suitable for topical pulmonary administration. -
BA8213 YonkenafilSummary: Yonkenafil (Tunodafil) is a novel phosphodiesterase 5 inhibitor that is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. -
BA8225 AyaninSummary: Ayanin is a biologically active flavonoid. -
BA8252 CAY10594Summary: CAY10594 is a potent inhibitor (in vitro = 140 nM -
BA8279 SR10221Summary: SR10221 is a non-covalent inverse agonist. -
BA8410 TabersonineSummary: Tabersonine is an indole alkaloid isolated primarily from periwinkle.

